Daily FNArena News

FNArena is one of few remaining truly independent providers of financial markets analysis, financial commentary and business news in Australia. Our Daily Financial News is not based on ASX lodgements or corporate press releases, but more so on updated views, insights and responses from stockbrokers and other experts. FNArena is not aligned with any financial institution, hence the moniker “independent”. We have a long history of publishing out-of-consensus views and market analysis. Our quest is not to be bullish or bearish, but to correctly assess future trends.

Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | SMSFundamentals | Technicals | Treasure Chest |

Previous Stories

Australian Listed Investment Company Report September 2022

Sep 05 2022 - Australia

Independent Investment Research updates developments among Australia’s listed investment companies and provides comparative data

FNArena Corporate Results Monitor – 02-09-2022

Sep 02 2022 - Australia

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

Growth A Gem in Michael Hill’s Crown

Sep 02 2022 - Small Caps

Michael Hill has again delivery strong growth, and looks to pivot from transformation to growth in the coming year

FNArena Corporate Results Monitor – 01-09-2022

Sep 01 2022 - Australia

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

Lovisa: More Growth, More Markets, More Growth

Sep 01 2022 - Small Caps

Lovisa Holdings continues its global takeover with significant store expansion into the US in the last year, as analysts suggest a move into the Chinese market could be on the cards

Shine Comes Off Adore Beauty

Aug 31 2022 - Small Caps

Cycling off lockdown benefits looks to prove challenging for Adore Beauty, with the online retailer reporting a -28% decline in sales in the first seven weeks of the new year

FNArena Corporate Results Monitor – 31-08-2022

Aug 31 2022 - Australia

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

Small Cap Reporting Season Highlights

Aug 31 2022 - Small Caps

Tim Boreham, with some help from Ausbil, lines up his small-cap favourites from the August reporting season in Australia

FNArena Corporate Results Monitor – 30-08-2022

Aug 30 2022 - Australia

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

S&P500: Consolidation Ahead

Aug 30 2022 - Technicals

Michael Gable of Fairmont Equities suggests the June low for the S&P500 may hold, with consolidation on the cards from here

« Older Stories
Newer Stories »

Analyse The Market From A Different Angle

ICARUS SIGNAL

Consensus price targets can be a useful tool to assess whether stocks are running too hard, or falling too deeply.
R-FACTOR

Relative ranking of ASX200 stocks in accordance with consensus forecasts for growth, valuation and yield.
SENTIMENT INDICATOR

Evaluate circa 400 ASX-listed stocks on the basis of High/Low expert sentiment, forecast dividend yield.

Latest News

1
The Market In Numbers – 2 May 2026

9:09 AM - Australia
2
ASX Winners And Losers Of Today – 01-05-26

May 01 2026 - Daily Market Reports
3
FNArena Corporate Results Monitor – 01-05-2026

May 01 2026 - Australia
4
Next Week At A Glance – 4-8 May 2026

May 01 2026 - Weekly Reports
5
Weekly Top Ten News Stories – 1 May 2026

May 01 2026 - Weekly Reports

Most Popular

1
FNArena Corporate Results Monitor – 03-04-2026

Apr 03 2026 - Australia
2
ASIC Watch: Reporting Failures Draw $1.1m In Single-Day Fines

Apr 16 2026 - Australia
3
Rudi’s View: Trump’s Circus & Technology’s Brave New World

Apr 09 2026 - Rudi's View
4
AI’s Power Demand Is Rewiring Global Markets

Apr 27 2026 - Commodities
5
In Brief: Reliance, Bannerman & Codan

May 01 2026 - Weekly Reports
6
The Biotech ‘Industrialisation’

Apr 20 2026 - Small Caps